ScFv intrabodies against N terminus and proline-rich (PRR) domains of Htt (VL12.3 and Happ1, respectively) reduce mHtt-induced toxicity and aggregation in an in vitro and corticostriatal brain slice models of HD (115). This evidence concerns the gene HTT and Huntington disease.